- Horsham PA, US Eric R. Thompson - Chalfont PA, US Nicholas R. Myslinski - Bensalem PA, US Steven F. Kemeny - Philadelphia PA, US Matthew N. Hart - Palmyra NJ, US
Assignee:
Pharmaceutical Manufacturing Research Services, Inc. - Horsham PA
International Classification:
A61K 9/48 A61K 31/485
Abstract:
The present disclosure relates to an oral, immediate release, abuse deterrent liquid filled capsule containing polyethylene glycol and at least one active pharmaceutical ingredient susceptible to abuse. The dosage form is abuse deterrent to parenteral administration. The present disclosure also relates to processes of preparing the dosage form.
Extended Release Abuse Deterrent Liquid Fill Dosage Form
- Horsham PA, US Eric R. Thompson - Chalfont PA, US Nicholas R. Myslinski - Bensalem PA, US Steven F. Kemeny - Philadelphia PA, US Matthew N. Hart - Palmyra NJ, US
Assignee:
Pharmaceutical Manufacturing Research Services, Inc. - Horsham PA
International Classification:
A61K 9/48 A61K 31/485
Abstract:
The present disclosure relates to an oral, extended release, abuse deterrent dosage form containing a controlled release agent, a second agent and/or polyethylene glycol, and at least one active pharmaceutical ingredient susceptible to abuse. The dosage form is stable at high temperatures and abuse deterrent to oral and parenteral administration via dose dumping, extraction, and purification. The present disclosure also relates to processes of preparing the dosage form.
- Horsham PA, US Eric R. Thompson - Chalfont PA, US Nicholas R. Myslinski - Bensalem PA, US Steven F. Kemeny - Philadelphia PA, US
Assignee:
Pharmaceutical Manufacturing Research Services, Inc. - Horsham PA
International Classification:
A61K 9/20 B29C 47/00 A61K 31/485
Abstract:
The present disclosure relates to an oral, extended release pill containing a drug which is homogenously spread throughout a matrix. The pill can be prepared using a hot melt extrusion process and a forming unit. The formed pill meets regulatory guidelines for extended release formulations and can be abuse deterrent to parenteral administration due at least to particle size, viscosity, or purity limitations.
- Horsham PA, US Eric R. Thompson - Chalfont PA, US Nicholas R. Myslinski - Bensalem PA, US Steven F. Kemeny - Philadelphia PA, US
Assignee:
Pharmaceutical Manufacturing Research Services, Inc. - Horsham PA
International Classification:
A61K 9/20 A61K 31/485
Abstract:
The present disclosure relates to an oral, extended release, abuse deterrent pill containing at least one active pharmaceutical ingredient susceptible to abuse which is homogenously spread throughout a matrix used to deter abuse. The pill can be prepared using a hot melt extrusion process and a forming unit. The formed pill meets regulatory guidelines for extended release formulations and is abuse deterrent to parenteral administration due at least to particle size, viscosity, or purity limitations.
- Horsham PA, US Eric R. Thompson - Chalfont PA, US Nicholas R. Myslinski - Bensalem PA, US Steven F. Kemeny - Philadelphia PA, US
Assignee:
Pharmaceutical Manufacturing Research Services, Inc. - Horsham PA
International Classification:
A61K 31/485 A61K 9/20
Abstract:
The present disclosure relates to an oral, immediate release, abuse deterrent pill containing at least one active pharmaceutical ingredient susceptible to abuse which is homogenously spread throughout a carrier matrix used to deter abuse. The pill is prepared using hot melt extrusion and a forming unit through a continuous process. The formed pill is abuse deterrent to parenteral administration due at least to particle size, viscosity, or purity limitations.
Extended Release Abuse Deterrent Liquid Fill Dosage Form
- Horsham PA, US Eric R. Thompson - Chalfont PA, US Nicholas R. Myslinski - Bensalem PA, US Steven F. Kemeny - Philadelphia PA, US Matthew N. Hart - Palmyra NJ, US
Assignee:
Pharmaceutical Manufacturing Research Services, Inc. - Horsham PA
International Classification:
A61K 31/485 A61K 9/48
Abstract:
The present disclosure relates to an oral, extended release, abuse deterrent dosage form containing a controlled release agent, a second agent and/or polyethylene glycol, and at least one active pharmaceutical ingredient susceptible to abuse. The dosage form is stable at high temperatures and abuse deterrent to oral and parenteral administration via dose dumping, extraction, and purification. The present disclosure also relates to processes of preparing the dosage form.
Immediate Release Abuse Deterrent Liquid Fill Dosage Form
- Horsham PA, US Eric R. Thompson - Chalfont PA, US Nicholas R. Myslinski - Bensalem PA, US Steven F. Kemeny - Philadelphia PA, US Matthew N. Hart - Palmyra NJ, US
Assignee:
Pharmaceutical Manufacturing Research Services, Inc. - Horsham PA
International Classification:
A61K 9/48 A61K 31/485
Abstract:
The present disclosure relates to an oral, immediate release, abuse deterrent liquid filled capsule containing polyethylene glycol and at least one active pharmaceutical ingredient susceptible to abuse. The dosage form is abuse deterrent to parenteral administration. The present disclosure also relates to processes of preparing the dosage form.
The present disclosure relates to an oral, extended release, abuse deterrent pill containing at least one active pharmaceutical ingredient susceptible to abuse which is homogenously spread throughout a matrix used to deter abuse. The pill can be prepared using a hot melt extrusion process and a forming unit. The formed pill meets regulatory guidelines for extended release formulations and is abuse deterrent to parenteral administration due at least to particle size, viscosity, or purity limitations.
Pmr
Assistant Director of Manufacturing
Drexel's Vascular Kinetics Lab Sep 2007 - Aug 2012
Graduate Researcher
Virginia Tech 2003 - 2007
Fulltime Student
Freedom Medical Jun 2006 - Aug 2006
Quality Engineering Intern
Virginia Tech Jan 2006 - May 2006
Research Assistant
Education:
Drexel University 2009 - 2012
Doctorates, Doctor of Philosophy, Philosophy, Mechanical Engineering
Drexel University 2007 - 2009
Master of Science, Masters, Biomedical Engineering
Virginia Tech 2003 - 2007
Bachelors, Bachelor of Science, Engineering
Skills:
Matlab Biomechanics Cell Culture Gmp Medical Devices Biomedical Engineering Cell Biomaterials Validation Research Finite Element Analysis Image Analysis Microsoft Office Microscopy Quality System Statistics Formulation Fda Engineering Research and Development Extrusion Quality Management Labview Imaging Cell Based Assays Cgmp Manufacturing Cgmp Practices Tablet Compression Quality By Design Computer Vision Pharmaceutical Process Development Process Improvement Batch Records Manufacturing R&D Quality Control
Interests:
Environment Health
Languages:
English
Youtube
Trvnyre trve 1/9
Gyrtsi v: 1991 Hossz: 88 perc rendez: John Flynn forgatknyvr: David Le...
Category:
Film & Animation
Uploaded:
18 Dec, 2010
Duration:
10m 9s
The Steve kzr. Kis Zsuzsi - Bukott Angyal (Fa...
The Steve kzr. Kis Zsuzsi - Bukott Angyal (Cilvaringz - Fallen Angel) ...
Category:
Music
Uploaded:
20 Aug, 2009
Duration:
2m 24s
Bullitt - Steve McQueen Famous Car Chase
*/ To see the high quality version, add '&fmt=18' behind the url. Minu...
kemeny, souk - kemery, ela. kemeny, souk Kemeny, Stephen kemeny, steve kemeny, steven Kemeny, Susie Kemeny, Szabolcs Kemeny, Tamas Kemeny, Tibor Kemeny, ...
Googleplus
Steven Kemeny
Lived:
Philadelphia, PA West Chester, PA Marlton, NJ Walnut Creek, CA West Chester, PA Blacksburg, VA Philadelphia, PA
Work:
Drexel University - Graduate Student (2007)
Education:
Drexel University - Mechanical Engineering, Drexel University - Biomedical Engineering, Virginia Polytechnic Institute and State University - Engineering Science and Mechanics
About:
I am current studying for a PhD. in mechanical engineering. I work in the Vascular Kinetics Laboratory.